Trinity Biotech - 11 Year Dividend History | TRIB
Historical dividend payout and yield for Trinity Biotech (TRIB) since 2013. The current TTM dividend payout for Trinity Biotech (TRIB) as of November 19, 2024 is $0.00. The current dividend yield for Trinity Biotech as of November 19, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.010B |
$0.057B |
|
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
